Inventor
PANDEY NIRANJAN B
US12 patents
⚠️ This page may combine multiple inventors who share the name “PANDEY NIRANJAN B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV JOHNS HOPKINS
6 patentsUS11981754B2May 14, 2024
Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases
UNIV JOHNS HOPKINS1 citations70
US10774112B2Sep 15, 2020
Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases
UNIV JOHNS HOPKINS1 citations70
US9802984B2Oct 31, 2017
Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases
UNIV JOHNS HOPKINS3 citations70
US11155603B2Oct 26, 2021
Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases
UNIV JOHNS HOPKINS0 citations58
US10106597B2Oct 23, 2018
Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases
UNIV JOHNS HOPKINS1 citations58
US10774131B2Sep 15, 2020
Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases
UNIV JOHNS HOPKINS0 citations48
JANSSEN PHARMACEUTICA NV
4 patentsUS7579356B2Aug 25, 2009
Thia-tetraazaacenaphthylene kinase inhibitors
JANSSEN PHARMACEUTICA NV9 citations80
US7605154B2Oct 20, 2009
Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors
JANSSEN PHARMACEUTICA NV2 citations58
US7659284B2Feb 9, 2010
Thiazolopyridine kinase inhibitors
JANSSEN PHARMACEUTICA NV0 citations40
US7427625B2Sep 23, 2008
Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
JANSSEN PHARMACEUTICA NV0 citations39